" 'Where is the missing heritability?' is a question asked frequently in genetic research. The difficulty seems to come down to the common disease/common variant hypothesis not holding up." » Read more
Bozeman, MT (August 17 , 2006) - Golden Helix, Inc. announced today the release of HelixTree 5.2, which includes a powerful new regression module for population-based association studies and an exclusive upgrade to PBAT (v3.5) for family-based association studies.
New feature highlights:
Start making significant discoveries today! HelixTree has been cited in nearly 100 peer reviewed articles and remains the fastest, most comprehensive and user-friendly SNP analysis package available!
About PBAT
PBAT is a comprehensive software package developed by Christoph Lange of the Harvard School of Public Health that contains tools that help with the design and analysis of a large variety of family-based association studies. Among these tools are power calculations that assess the power of family-based association tests (FBATs) and screening methodologies that help address the multiple-comparison problem in whole-genome association studies. The power of PBAT was confirmed recently in a whole-genome study where it was used to identify the first common genetic variant linked to obesity. It is noteworthy that the study’s findings (published in the April 14, 2006 edition of Science), were replicated in at least a half dozen other studies. For more information about PBAT please visit: www.goldenhelix.com/pbat.html
About Golden Helix, Inc.
Founded in 1998 in Bozeman, MT, Golden Helix is a leading provider of data analysis software products and services designed to accelerate life science research and increase pharmaceutical R&D productivity. The company's products enable hundreds of researchers at the world's top pharmaceutical, biotech and non-profit research organizations to discover the genes that cause disease, improve target and lead discovery processes, and advance pharmacogenetic initiatives. Its products have been cited in nearly 100 peer reviewed publications that detail ground-breaking research for discovering the genetic and environmental basis of disease and creating safer and more effective medicines.
Golden Helix is committed to Accelerating the Quest for Significance.
For more information, please visit www.goldenhelix.com.
###
Media Contact:
Josh Forsythe
Director of Marketing
Golden Helix, Inc.
406-585-8137 x202
jlforsythe[at]goldenhelix.com
© 2010 Golden Helix, Inc. All Rights Reserved